Optimi Health appoints Dr. Michael Blough Chief Clinical Development Officer

Optimi Health said it appointed Dr. Michael Blough as Chief Clinical Development Officer, supporting its planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSD.